SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors deramiocel for Duchenne muscular dystrophy, with a letter from 28 HOPE-3 investigators urging approval and disputing the agencys concerns about the trial data. Many traders see the letter and clinical data as strengthening the approval case and speculate about a short squeeze, while others emphasize that a rejection or delay remains possible.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,192,071.85523712. The last known price of Ethereum is 2,238.82507201 USD and is down -7.69 over the last 24 hours. It is currently trading on 14268 active market(s) with $19,113,383,798.40 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereums sharp decline and failed rebound amid a broader crypto selloff dominate the discussion, with traders also voicing concern about the Binance hack and market uncertainty. Bearish traders expect further losses, while dip buyers argue the selloff may be nearing a bottom.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs quarterly update raised its full-year revenue outlook, supported by a Sanofi milestone tied to its flu-COVID combination vaccine trial and its licensing strategy. Despite the stronger results, traders focused on the shares decline, the long wait for recurring revenue and new partnerships, and managements later profitability target.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

A sharp AI and semiconductor selloff has fueled concern that political pushback and proposed pauses on data-center construction could slow AI infrastructure spending and chip demand. Traders are split between warnings that the AI growth outlook is being repriced and views that the reaction is overdone because no new restrictions are in place and demand remains strong.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Q3 results sparked a sharp selloff, with traders focused on softer revenue and declining policies in force as signs that growth is stalling, despite continued profitability. Bulls point to earnings and share buybacks as support, while bears argue that weak policy growth and top-line trends outweigh those positives.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,098.29866033 USD and is down -5.65 over the last 24 hours. It is currently trading on 12776 active market(s) with $48,501,391,251.88 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp decline is being discussed alongside a broader risk-off selloff in tech and other assets, with traders pointing to market de-risking and liquidations. The community is split between fears of further downside and calls that the pullback is a buying opportunity; political explanations are also circulating but remain speculative.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Concerns about DaVitas preliminary outlook for lower DefenCath reimbursement through 2027 have fueled heavy selling, with traders debating whether the warning signals weaker revenue and adoption. Some argue the projection is uncertain because DaVita said it had limited visibility and point to CMSs initial 2027 reimbursement decision as a counterpoint; others remain concerned about quarterly recalculations and managements response.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyfts Q3 results are driving attention after a revenue and earnings miss, with legal, tax and regulatory reserves weighing on reported results. Traders are debating the selloff against growth in bookings and riders, stronger adjusted EBITDA, and broadly steady Q4 guidance.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

A sharp semiconductor selloff has centered on traders fears that the Democratic midterm sweep and data-center opposition could slow AI infrastructure spending, weakening chip demand. Some see policy risk as an added trigger to an existing reassessment of AI valuations, capex returns, and financing; others view the drop as an overreaction and a potential buying opportunity.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is selling off amid concerns that post-election regulation could slow AI data-center construction, while heavy financing needs and reports of a canceled chip-leasing deal have intensified doubts about whether its infrastructure commitments will translate into cash flow. Traders disagree on the outlook: bears see mounting execution and debt risks, while bulls argue AI demand remains strong and existing capacity could benefit if new projects face delays.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IFF Earnings Beat Estimates in Q3 on Taste & Scent Strength

International Flavors beats Q3 earnings and sales estimates as Taste and Scent deliver strong growth.


International Flavors (IFF) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for International Flavors (IFF) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

International Flavors (IFF) Surpasses Q3 Earnings and Revenue Estimates

International Flavors (IFF) delivered earnings and revenue surprises of +2.47% and +1.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

IFF Reports Third Quarter 2026 Results

IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the Food Ingredients disposal group), and the Soy Crush, Concentrates...

International Flavors to Report Q3 Earnings: What's in the Offing?

IFF heads into the Q3 earnings release facing revenue and profit declines, as rising raw material and operating costs challenge margin gains from productivity efforts.

Minerals Technologies (MTX) Q3 Earnings and Revenues Top Estimates

Minerals Technologies (MTX) delivered earnings and revenue surprises of +5.52% and +0.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

IFF Declares Dividend for Fourth Quarter 2026

IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 13, 2027 to shareholders of record as of December 19, 2026. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and...

IFF Identifies Ten Consumer Moments Reshaping Food and Beverage Innovation in the GLP-1 Era

IFF (NYSE: IFF)a global leader in flavors, fragrances and health and biosciences, today launched its latest report, GLP-1 Consumer Moments of Opportunity. The report uncovers ten emerging consumer moments that reflect the changing needs of consumers using GLP-1 medications. This press release...

International Flavors (IFF) Expected to Beat Earnings Estimates: Should You Buy?

International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will International Flavors (IFF) Beat Estimates Again in Its Next Earnings Report?

International Flavors (IFF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

$IFF Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.58 up 13.73% YoY
• Reported revenue of $1.94B down -27.91% YoY
• IFF raised the low end of full-year 2026 guidance: $7.5B $7.6B and adjusted operating $1.55B $1.6B; comparable currency-neutral sales growth 3% to 4%.

Stocktwits

International Flavors & Fragrances Inc.

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.58 up 13.73% YoY
• Reported revenue of $1.94B down -27.91% YoY
• IFF raised the low end of full-year 2026 guidance: $7.5B $7.6B and adjusted operating $1.55B $1.6B; comparable currency-neutral sales growth 3% to 4%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $0.58 up 13.73% YoY
• Reported revenue of $1.94B down -27.91% YoY
• IFF raised the low end of full-year 2026 guidance: $7.5B $7.6B and adjusted operating $1.55B $1.6B; comparable currency-neutral sales growth 3% to 4%.

IFF expects softer fourth-quarter profitability, reported a -$134M continuing-operations pretax loss including a $236M held-for-sale loss, and recorded regulatory costs tied to fragrance-business investigations.

IFF reported sales and adjusted EBITDA growth; Taste and Scent currency-neutral sales increased, with Greater Asia leading Taste; first-nine-month cash flow increased year over year, and IFF completed $500M share repurchase.

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Bullish Sentiment

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Current Price	$86.36
Prev Close	$87.67
Open	$88.10
Dividend Yield	2.37%
50-Day Moving Average	$87.17
Beta	0.64
Avg. Volume	2.09M
PE Ratio	122.53

52-Week High	$95.27
52-Week Low	$61.73
Market Capitalization	$21.95B
EPS (Annual)	-$1.41
Price to Book	1.63
Revenue Per Employee	$506,511.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

IFF Fundamentals